Screens cell-free DNA in maternal blood for common trisomies, sex chromosome abnormalities and a broader range of chromosome conditions.
Used from 10 weeks of pregnancy onwards for broader prenatal chromosome screening, including Down, Edwards and Patau syndromes, sex chromosome abnormalities and selected additional chromosome conditions.